Evidence map›Paper›PMID 34299258›Full record

ArticleInternational journal of molecular sciences2021

Resveratrol Is a Natural Inhibitor of Human Intestinal Mast Cell Activation and Phosphorylation of Mitochondrial ERK1/2 and STAT3.

Sabrina Bilotta, Lakshmi Bhargavi Paruchuru, Katharina Feilhauer, Jörg Köninger, Axel Lorentz

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Mast Cells: When the Best Defense Is an Attack?International journal of molecular sciences · 2022
    Article
  13. Bioactive Compounds fromMolecules (Basel, Switzerland) · 2022
    Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Sabrina BilottaDepartment of Nutritional Medicine, University of Hohenheim, Fruwirthstraße 12, 70593 Stuttgart, Germany.
Lakshmi Bhargavi ParuchuruDepartment of Biochemistry and Molecular Biology, Institute for Medical Research-Israel-Canada, The Hebrew University of Jerusalem, Jerusalem 91120, Israel.ORCID 0000-0002-2511-0797
Katharina FeilhauerClinic for Visceral Surgery, Katharinenhospital, Kriegsbergstraße 60, 70174 Stuttgart, Germany.
Jörg KöningerClinic for Visceral Surgery, Katharinenhospital, Kriegsbergstraße 60, 70174 Stuttgart, Germany.
Axel LorentzDepartment of Nutritional Medicine, University of Hohenheim, Fruwirthstraße 12, 70593 Stuttgart, Germany.
Katharinenhospital · DEUniversity of Hohenheim · DEHebrew University of Jerusalem · IL

Funding

German-Israeli Foundation for Scientific Research and Development I-1469-414.13/2018
6 · The paper itself

Abstract

Mast cells play a critical role as main effector cells in allergic and other inflammatory diseases. Usage of anti-inflammatory nutraceuticals could be of interest for affected patients. Resveratrol, a natural polyphenol found in red grapes, is known for its positive properties. Here, we analyzed the effects of resveratrol on FcεRI-mediated activation of mature human mast cells isolated from intestinal tissue (hiMC). Resveratrol inhibited degranulation and expression of cytokines and chemokines such as CXCL8, CCL2, CCL3, CCL4, and TNF-α in a dose-dependent manner. Further, resveratrol inhibited the phosphorylation of extracellular signal-regulated kinase (ERK) 1/2 and signal transducer and activator of transcription (STAT) 3. ERK1/2 is known to be involved in cytokine expression of hiMC and to directly interact with STAT3. Mitochondrial STAT3 is phosphorylated by ERK1/2 and contributes to mast cell degranulation. We were able to isolate mitochondrial fractions from small hiMC numbers and could show that activation of mitochondrial STAT3 and ERK1/2 in hiMC was also inhibited by resveratrol. Our results indicate that resveratrol inhibits hiMC activation by inhibiting the phosphorylation of mitochondrial and nuclear ERK1/2 and STAT3, and it could be considered as an anti-inflammatory nutraceutical in the treatment of mast cell-associated diseases.

Indexed as

Cell DegranulationChemokinesCytokinesHumansImmunoglobulin EIntestinal MucosaIntestinesMAP Kinase Signaling SystemMast CellsMitochondriaMitogen-Activated Protein Kinase 3PhosphorylationReceptors, IgEResveratrolSTAT3 Transcription FactorChemokinesCytokinesImmunoglobulin EMAPK3 protein, humanMitogen-Activated Protein Kinase 3Receptors, IgEResveratrolSTAT3 protein, humanSTAT3 Transcription FactorallergyERK1/2mast cellsmitochondrial signalingnutraceuticalspolyphenolsresveratrolSTAT3

Identifiers

PMID34299258
PMCPMC8307672
OpenAlexW3183991840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.